JFLLIFE

JFL Life Sciences Share Price

₹35.00 +1.35 (4.01%)

09 Dec, 2024 15:18

SIP TrendupStart SIP in JFLLIFE

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹37
  • Open Price₹0
  • Previous Close₹33
  • Volume0

Investment Returns

  • Over 1 Month + 24.33%
  • Over 3 Month + 83.53%
  • Over 6 Month + 169.65%
  • Over 1 Year + 144.24%
SIP Lightning

Smart Investing Starts Here Start SIP with JFL Life Sciences for Steady Growth!

Invest Now

JFL Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 116
  • P/B Ratio
  • 3.2
  • Average True Range
  • 1.31
  • EPS
  • 1
  • Dividend Yield
  • 0
  • MACD Signal
  • 2.58
  • RSI
  • 65.85
  • MFI
  • 80.96

JFL Life Sciences Financials

JFL Life Sciences Technicals

EMA & SMA

Current Price
₹35.00
+ 1.35 (4.01%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹30.15
  • 50 Day
  • ₹26.15
  • 100 Day
  • ₹22.79
  • 200 Day
  • ₹19.75

Resistance and Support

33 Pivot Speed
  • R3 33.00
  • R2 33.00
  • R1 33.00
  • S1 33.00
  • S2 33.00
  • S3 33.00

What's your outlook on JFL Life Sciences?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Jfl Life Sciences has an operating revenue of Rs. 155.74 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 8% is okay, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 32% and 85% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 93 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 30 indicates it belongs to a strong industry group of Medical-Whlsle Drg/Suppl and a Master Score of D is close to being the worst. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

JFL Life Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-02 Bonus issue, Dividend & Fund Raising
2024-05-27 Audited Results
2023-11-08 Quarterly Results
2023-05-27 Audited Results
Date Purpose Remarks
2024-09-24 Bonus Rs.0.00 issue in the ratio of 2:1 of Rs. 10/-.

JFL Life Sciences F&O

JFL Life Sciences Shareholding Pattern

67.47%
28.37%
4.16%

About JFL Life Sciences

  • NSE Symbol
  • JFLLIFE
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Smiral Ashwinkumar Patel
  • ISIN
  • INE0LA901015

Similar Stocks to JFL Life Sciences

JFL Life Sciences FAQs

JFL Life Sciences share price is ₹35 As on 09 December, 2024 | 15:04

The Market Cap of JFL Life Sciences is ₹115.5 Cr As on 09 December, 2024 | 15:04

The P/E ratio of JFL Life Sciences is As on 09 December, 2024 | 15:04

The PB ratio of JFL Life Sciences is 3.2 As on 09 December, 2024 | 15:04

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23